Greg LeMond has spoken out on Chris Froome's salbutamol case, arguing that the Tour de France and Vuelta a España winner is solely accountable for what's in his system, and labelling his predicted defence as "ridiculous".
Froome returned an adverse analytical finding (AAF) for salbutamol at the Vuelta in September, when twice the permitted level of the asthma medication was found in his urine.
As salbutamol is a 'specified' substance on WADA's prohibited list, Froome has not been provisionally suspended but will face a ban unless he can convince the anti-doping authorities that he did not exceed permitted dosage and his sample was skewed by other factors.
"The fallacy that salbutamol does not improve performance is only true if you use it as prescribed. Taken orally or by injection it acts as an anabolic steroid, similar to clenbuterol, the drug that Alberto Contador was positive for," said LeMond.
"That is the most ridiculous excuse I have ever heard. If this is what he claims, then it's simple, he broke the rules and should be punished accordingly."
- A lot of explaining to do: The questions raised by the Chris Froome salbutamol case
- Chris Froome in 'horrible situation' after salbutamol test
- Will Chris Froome's salbutamol result sink Team Sky?
- Timeline of Chris Froome's adverse analytical finding for salbutamol
'Brailsford is secretive'
LeMond also delivered a damning criticism of Team Sky more generally. The British team was created with a commitment to transparency and riding clean but their credibility has been called into question over the years, most notably by the 'jiffy bag' scandal surrounding Bradley Wiggins.
Thank you for signing up to Cycling News. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.